Historical Valuation
Zepp Health Corp (ZEPP) is now in the Fair zone, suggesting that its current forward PS ratio of 1.46 is considered Fairly compared with the five-year average of -36.69. The fair price of Zepp Health Corp (ZEPP) is between 20.30 to 51.09 according to relative valuation methord.
Relative Value
Fair Zone
20.30-51.09
Current Price：28.08
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Zepp Health Corp (ZEPP) has a current Price-to-Book (P/B) ratio of 1.96. Compared to its 3-year average P/B ratio of 0.56 , the current P/B ratio is approximately 247.61% higher. Relative to its 5-year average P/B ratio of 0.71, the current P/B ratio is about 174.74% higher. Zepp Health Corp (ZEPP) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -4.20%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -3.79% , the current FCF yield is about -100.00% lower.
P/B
Median3y
0.56
Median5y
0.71
FCF Yield
Median3y
-4.20
Median5y
-3.79
Competitors Valuation Multiple
AI Analysis for ZEPP
The average P/S ratio for ZEPP competitors is 4.33, providing a benchmark for relative valuation. Zepp Health Corp Corp (ZEPP.N) exhibits a P/S ratio of 1.46, which is -66.38% above the industry average. Given its robust revenue growth of 78.49%, this premium appears sustainable.
Performance Decomposition
AI Analysis for ZEPP
1Y
3Y
5Y
Market capitalization of ZEPP increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ZEPP in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is ZEPP currently overvalued or undervalued?
Zepp Health Corp (ZEPP) is now in the Fair zone, suggesting that its current forward PS ratio of 1.46 is considered Fairly compared with the five-year average of -36.69. The fair price of Zepp Health Corp (ZEPP) is between 20.30 to 51.09 according to relative valuation methord.
What is Zepp Health Corp (ZEPP) fair value?
ZEPP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Zepp Health Corp (ZEPP) is between 20.30 to 51.09 according to relative valuation methord.
How does ZEPP's valuation metrics compare to the industry average?
The average P/S ratio for ZEPP's competitors is 4.33, providing a benchmark for relative valuation. Zepp Health Corp Corp (ZEPP) exhibits a P/S ratio of 1.46, which is -66.38% above the industry average. Given its robust revenue growth of 78.49%, this premium appears sustainable.
What is the current P/B ratio for Zepp Health Corp (ZEPP) as of Jan 09 2026?
As of Jan 09 2026, Zepp Health Corp (ZEPP) has a P/B ratio of 1.96. This indicates that the market values ZEPP at 1.96 times its book value.
What is the current FCF Yield for Zepp Health Corp (ZEPP) as of Jan 09 2026?
As of Jan 09 2026, Zepp Health Corp (ZEPP) has a FCF Yield of 0.00%. This means that for every dollar of Zepp Health Corp’s market capitalization, the company generates 0.00 cents in free cash flow.
What is the current Forward P/E ratio for Zepp Health Corp (ZEPP) as of Jan 09 2026?
As of Jan 09 2026, Zepp Health Corp (ZEPP) has a Forward P/E ratio of -329.76. This means the market is willing to pay $-329.76 for every dollar of Zepp Health Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Zepp Health Corp (ZEPP) as of Jan 09 2026?
As of Jan 09 2026, Zepp Health Corp (ZEPP) has a Forward P/S ratio of 1.46. This means the market is valuing ZEPP at $1.46 for every dollar of expected revenue over the next 12 months.